Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
PeterMD and Dr. Uzzi Reiss, MD Announce Partnership to Revolutionize Female Hormone Therapy and Anti-Aging
PeterMD, one of the largest telemedicine providers in North America focusing on Testosterone Replacement Therapy and Male […]
Rocket Pharmaceuticals Announces Leadership Expansion to Support Company on Evolution Towards Commercial Stage
Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]
Cystic Fibrosis Foundation Commits Up to $15.5M in Additional Funding for Potential Enzyme Therapy
The Cystic Fibrosis Foundation recently agreed to provide up to $15.5 million to Anagram Therapeutics […]
Solvay Announces Strategic Collaboration With Ginkgo Bioworks And Expands Its R&I Footprint In The United States
Solvay, a leading science and materials company whose technologies bring benefits to many aspects of […]
Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study
Vivani Medical, an emerging biopharmaceutical company that develops miniaturized, subdermal implants has announced that the […]
Heron Therapeutics Announces New CEO and Board Chairman
Heron Therapeutics, a commercial-stage biotechnology company focused on improving the lives of patients by developing […]
Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals
Evergreen Discovery, a leading radiopharmaceutical drug development company with a focus on the treatment and […]
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the FDA
Vertex Pharmaceuticals and CRISPR Therapeutics today announced the completion of the rolling Biologics License Applications […]
BioSenic Appoints Lieven Huysse, MD, as Chief Medical Officer (CMO)
BioSenic, the company specializing in serious autoimmune and inflammatory diseases and cell repair, today announces […]
SynAct Pharma Appoints Torbjørn Bjerke as New CEO
SynAct Pharma has announced the appointment of the company’s current Chairman Torbjørn Bjerke MD, as […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more